Pierre Fabre (CDMO)
Is this your company? Claim this profile
Drug Product
Regulatory, Tech Transfer & Support Services
Company Overview
About
Pierre Fabre (CDMO) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:France
Founded:2007
Employees:1,402
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
North America
Manufacturing Facilities
1 site worldwide
Pierre Fabre Medicament
16 rue Jean ROSTAND, Gaillac, Occitanie, 81600
Site Capabilities
1 capabilityAPI MANUFACTURE
Regulatory Approvals
Drug Approval 4PAG8J
Health Canada · #APR-2OOFOBTM · 2019-03-01
Drug Approval XJZY98
Health Canada · #APR-50GLMAA9 · 2020-03-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-B22WI90O
Issued: 2020-08-26
Expires: 2025-09-08
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-BC21NQBX
Issued: 2020-10-27
Expires: 2025-04-11
Loading CDMO intelligence...
Key facts about Pierre Fabre (CDMO)
- Pierre Fabre (CDMO) is headquartered in France.
- Pierre Fabre (CDMO) was founded in 2007.
- Pierre Fabre (CDMO) has 1,402 employees.
- Pierre Fabre (CDMO) has one manufacturing site listed on CDMO Hub, in Gaillac, France.
- Pierre Fabre (CDMO)'s capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Pierre Fabre (CDMO)
Directory pages this company appears in, each with the full list of matching manufacturers.